Pancreas
RESEARCH
The field of transplantation is one of rapid growth and development. Texas Transplant Group Physicians are committed to research and offer clinical trials to patients as a means of improving quality of care now and in the future. Physicians with the Texas Transplant Physician Group are actively involved in different clinical trials that explore state-of-the-art therapies for a wide range of diseases.
A clinical trial is a research treatment regimen designed to answer specific questions about new therapies or new ways of using known treatments. Clinical trials are used to determine whether new drugs or treatments are both safe, effective, and demonstrate an improvement over current treatment regimens.
Patients benefit not only from the level of experience attained by physicians at the most active pancreas program in Texas, but also from the extensive clinical research programs which offer access to the newest developments in transplant management and medications.
Immunosuppression is an intricate part of a patient’s post-transplant medication regimen. Texas Transplant Institute maintains ongoing trials to find new combinations of medications to decrease side effects and increase effectiveness of immunosuppressive therapies. Other studies are helping develop induction therapies to prevent or lower rejection of newly transplanted kidneys.
To view a list of current clinical trials and review a glossary of clinical terms click below:
Current Pancreas Transplant Trials
Glossary of Clinical Terms
RESEARCH DEPARTMENT CONTACT INFORMATION
Texas Transplant Institute
7711 Louis Pasteur, Suite 707
San Antonio, Texas 78229
(210) 575-4238